January 2, 2019 07:02 AM EST
Bioregnum
Opinion

New Year’s Day price hikes on block­buster drugs set the stage for a big de­bate

Al­ler­gan, Pfiz­er, Bris­tol-My­ers Squibb, Bio­gen and oth­er top drug­mak­ers all cel­e­brat­ed the New Year’s with a tra­di­tion­al boost in the price of their top drugs …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Trump asks 'very tough hom­bre' Dr. Oz to lead MFN talks

End­points 100 biotech sur­vey: Wel­come to the sum­mer of biotech’s dis­con­tent

Big leas­es, big­ger re­grets: Biotech slump turns swanky of­fices from as­set in­to li­a­bil­i­ty

About 5% of CBER and CDER left af­ter FDA staff cuts, analy­sis finds

US warns drug­mak­ers against mis­rep­re­sent­ing cost of im­port­ed prod­ucts

sponsored

Does your sup­ply chain hold up un­der pres­sure for high-risk tem­per­a­ture-crit­i­cal ship­ments?

A service from the Financial Times